Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 3,800 shares at $23.40 ($88K) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Scheduled sale ($88k) by COO & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.47 | 1,497 | $34K | 38.4% |
| 2 | $23.40 | 2,103 | $49K | 56.1% |
| 3 | $24.07 | 200 | $5K | 5.5% |
| Total | $23.07 avg | 3,800 | $88K | 100% |
| Filing → |
| STOK | SELL | 2024-04-03 | $1.6M | — | Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2021-12-03 | $139K | — | Filing → |